Emulate
Emulate understand that animal studies and reductionist models are limited because they are not based on integrated human biology. By leveraging 21st century technologies, they are able to overcome these limitations with living human in vitro models that empower researchers to explore the biological mechanisms of health and disease. These microphysiological systems (MPS), commonly known as organ-chips, are setting a new standard for how we study biology and develop drugs, therapies and cures for those who need them most.
Latest Emulate Content
eBook
An Introduction to Organ-on-a-Chip Technology
This eBook provides an introduction to Organ-on-a-Chip technology and highlights the latest solutions available to support drug discovery.
Webinar
Predictive Toxicology: Organ-Chips Demonstrate Superior Performance to Animal Models and Spheroids
On-Demand
To explore how this challenge might be approached, 780 human Liver-Chips were analyzed to determine their ability to predict drug-induced liver injury caused by small molecules.
Industry Insight
When We Become Leaders, How Do We Lead Science Towards Gender Equity?
Emulate's chief scientific officer, Dr. Lorna Ewart, talks about inspiring a new generation of women in STEM.
Article
Protecting Patients From Toxic Drugs Requires Modernization
This article outlines some of the drawbacks associated with current models used in drug toxicity studies and highlights how organ-chips could enable a move towards safer, efficient and more humane drug development.
Advertisement
